{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T17:09:20Z","timestamp":1793120960656,"version":"4.5.0"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010564","name":"Deutsche Zentrum f\u00fcr Lungenforschung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010564","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Immunology"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.molimm.2020.12.027","type":"journal-article","created":{"date-parts":[[2021,1,12]],"date-time":"2021-01-12T23:24:10Z","timestamp":1610493850000},"page":"112-120","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Autoantibodies against C5aR1, C3aR1, CXCR3, and CXCR4 are decreased in primary Sjogren\u2019s syndrome"],"prefix":"10.1016","volume":"131","author":[{"given":"Xiaoyang","family":"Yue","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengyuan","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junping","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junfeng","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiaoniang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zuguo","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiao","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antje","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harald","family":"Heidecke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela","family":"Riemekasten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9847-8800","authenticated-orcid":false,"given":"Frank","family":"Petersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinhua","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.molimm.2020.12.027_bib0005","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1002\/art.27584","article-title":"2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative","volume":"62","author":"Aletaha","year":"2010","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.molimm.2020.12.027_bib0010","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1111\/jop.12756","article-title":"Inverse correlation between the number of CXCR3 + macrophages and the severity of inflammatory lesions in Sj\u00f6gren\u2019s syndrome salivary glands: a pilot study","volume":"47","author":"Aota","year":"2018","journal-title":"J. Oral Pathol. Med."},{"key":"10.1016\/j.molimm.2020.12.027_bib0015","doi-asserted-by":"crossref","first-page":"3120","DOI":"10.1016\/j.celrep.2019.08.042","article-title":"The sympathetic nervous system mitigates CNS autoimmunity via \u03b22-adrenergic receptor signaling in immune cells","volume":"28","author":"Araujo","year":"2019","journal-title":"Cell Rep."},{"key":"10.1016\/j.molimm.2020.12.027_bib0020","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1046\/j.1365-2249.1996.42748.x","article-title":"Circulating antibodies against rat parotid gland M3 muscarinic receptors in primary Sj\u00f6gren\u2019s syndrome","volume":"104","author":"Bacman","year":"1996","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.molimm.2020.12.027_bib0025","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1076\/ceyr.17.12.1135.5124","article-title":"Human primary Sj\u00f6gren\u2019s syndrome autoantibodies as mediators of nitric oxide release coupled to lacrimal gland muscarinic acetylcholine receptors","volume":"17","author":"Bacman","year":"1998","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.molimm.2020.12.027_bib0030","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.3390\/ijms19051269","article-title":"VEGF (Vascular endothelial growth factor) and fibrotic lung disease","volume":"19","author":"Barratt","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.molimm.2020.12.027_bib0035","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1164\/rccm.201403-0442OC","article-title":"Vascular receptor autoantibodies in pulmonary arterial hypertension associated with systemic sclerosis","volume":"190","author":"Becker","year":"2014","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.molimm.2020.12.027_bib0040","doi-asserted-by":"crossref","first-page":"191","DOI":"10.7150\/ijms.17718","article-title":"Reviewing primary Sj\u00f6gren\u2019s syndrome: beyond the dryness - from pathophysiology to diagnosis and treatment","volume":"14","author":"Both","year":"2017","journal-title":"Int. J. Med. Sci."},{"key":"10.1016\/j.molimm.2020.12.027_bib0045","doi-asserted-by":"crossref","first-page":"5224","DOI":"10.1038\/s41467-018-07598-9","article-title":"GPCR-specific autoantibody signatures are associated with physiological and pathological immune homeostasis","volume":"9","author":"Cabral-Marques","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.molimm.2020.12.027_bib0050","first-page":"1342","article-title":"Failure to detect antibodies to extracellular loop peptides of the muscarinic M3 receptor in primary Sj\u00f6gren\u2019s syndrome","volume":"29","author":"Cavill","year":"2002","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.molimm.2020.12.027_bib0055","first-page":"28","article-title":"Biomarkers of rheumatoid arthritis-associated interstitial lung disease","volume":"67","author":"Chen","year":"2015","journal-title":"."},{"key":"10.1016\/j.molimm.2020.12.027_bib0060","doi-asserted-by":"crossref","first-page":"e0149485","DOI":"10.1371\/journal.pone.0149485","article-title":"Autoantibodies against the second extracellular loop of M3R do neither induce nor indicate primary Sj\u00f6gren\u2019s syndrome","volume":"11","author":"Chen","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.molimm.2020.12.027_bib0065","doi-asserted-by":"crossref","first-page":"10101","DOI":"10.1073\/pnas.0804286105","article-title":"CXCR4-CCR5: a couple modulating T cell functions","volume":"105","author":"Contento","year":"2008","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.molimm.2020.12.027_bib0070","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.4049\/jimmunol.1501798","article-title":"CXCR3 blockade inhibits T cell migration into the skin and prevents development of Alopecia Areata","volume":"197","author":"Dai","year":"2016","journal-title":"J. Immunol."},{"key":"10.1016\/j.molimm.2020.12.027_bib0075","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.preteyeres.2009.04.003","article-title":"Neural regulation of lacrimal gland secretory processes: relevance in dry eye diseases","volume":"28","author":"Dartt","year":"2009","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.molimm.2020.12.027_bib0080","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1093\/rheumatology\/keh389","article-title":"Putative anti-muscarinic antibodies cannot be detected in patients with primary Sj\u00f6gren\u2019s syndrome using conventional immunological approaches","volume":"43","author":"Dawson","year":"2004","journal-title":"Rheumatology"},{"key":"10.1016\/j.molimm.2020.12.027_bib0085","doi-asserted-by":"crossref","first-page":"3090","DOI":"10.1002\/art.23869","article-title":"Disrupted brain-immune system-joint communication during experimental arthritis","volume":"58","author":"del Rey","year":"2008","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.molimm.2020.12.027_bib0090","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1056\/NEJMoa035717","article-title":"Angiotensin II type 1-receptor activating antibodies in renal-allograft rejection","volume":"352","author":"Dragun","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.molimm.2020.12.027_bib0095","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1056\/NEJMoa035717","article-title":"Angiotensin II type 1\u2013receptor activating antibodies in renal-allograft rejection","volume":"352","author":"Dragun","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.molimm.2020.12.027_bib0100","first-page":"651","article-title":"Serologic features of primary Sj\u00f6gren\u2019s syndrome: clinical and prognostic correlation","volume":"7","author":"Garc\u00eda-Carrasco","year":"2012","journal-title":"Int. J. Clin."},{"key":"10.1016\/j.molimm.2020.12.027_bib0105","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1124\/mol.66.2.260","article-title":"Cholinergic stimulation of salivary secretion studied with M1 and M3 muscarinic receptor single- and double-knockout mice","volume":"66","author":"Gautam","year":"2004","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.molimm.2020.12.027_bib0110","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1172\/JCI0214121","article-title":"Association of BAFF\/BLyS overexpression and altered B cell differentiation with Sj\u00f6gren\u2019s syndrome","volume":"109","author":"Groom","year":"2002","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.molimm.2020.12.027_bib0115","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1002\/art.21129","article-title":"Dysregulation of chemokine receptor expression and function by B cells of patients with primary Sj\u00f6gren\u2019s syndrome","volume":"52","author":"Hansen","year":"2005","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.molimm.2020.12.027_bib0120","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1365-2567.2007.02614.x","article-title":"B-lymphocyte depletion ameliorates Sj\u00f6gren\u2019s syndrome in Id3 knockout mice","volume":"122","author":"Hayakawa","year":"2007","journal-title":"Immunology"},{"key":"10.1016\/j.molimm.2020.12.027_bib0125","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1146\/annurev.pa.30.040190.003221","article-title":"Muscarinic receptor subtypes","volume":"30","author":"Hulme","year":"1990","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.molimm.2020.12.027_bib0130","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.jaut.2010.08.004","article-title":"Pathogenic role of immune response to M3 muscarinic acetylcholine receptor in Sjogren\u2019s syndrome-like sialoadenitis","volume":"35","author":"Iizuka","year":"2010","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.molimm.2020.12.027_bib0135","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1146\/annurev-pharmtox-032112-135923","article-title":"Structure-function of the G protein\u2013coupled receptor superfamily","volume":"53","author":"Katritch","year":"2013","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.molimm.2020.12.027_bib0140","doi-asserted-by":"crossref","first-page":"R29","DOI":"10.1186\/ar4457","article-title":"Autoantibodies to angiotensin and endothelin receptors in systemic sclerosis induce cellular and systemic events associated with disease pathogenesis","volume":"16","author":"Kill","year":"2014","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.molimm.2020.12.027_bib0145","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/S0167-5699(00)01747-3","article-title":"Norepinephrine: a messenger from the brain to the immune system","volume":"21","author":"Kohm","year":"2000","journal-title":"Immunol. Today"},{"key":"10.1016\/j.molimm.2020.12.027_bib0150","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s00005-014-0310-1","article-title":"The role of endothelin-1 and endothelin receptor antagonists in inflammatory response and sepsis","volume":"63","author":"Kowalczyk","year":"2015","journal-title":"Arch. Immunol. Ther. Exp. (Warsz.)"},{"key":"10.1016\/j.molimm.2020.12.027_bib0155","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1023\/B:HIJO.0000032355.66152.b8","article-title":"CXCR4-SDF-1 signalling, locomotion, chemotaxis and adhesion","volume":"35","author":"Kucia","year":"2004","journal-title":"J. Mol. Histol."},{"key":"10.1016\/j.molimm.2020.12.027_bib0160","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1006\/brbi.1996.0034","article-title":"The autonomic nervous system and the immune system in juvenile rheumatoid arthritis","volume":"10","author":"Kuis","year":"1996","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.molimm.2020.12.027_bib0165","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jaut.2013.11.001","article-title":"A comprehensive review of autoantibodies in primary Sjogren\u2019s syndrome: clinical phenotypes and regulatory mechanisms","volume":"51","author":"Kyriakidis","year":"2014","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.molimm.2020.12.027_bib0170","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1111\/j.1749-6632.2009.04813.x","article-title":"CXCR3, inflammation, and autoimmune diseases","volume":"1173","author":"Lacotte","year":"2009","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.molimm.2020.12.027_bib0175","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.4049\/jimmunol.180.3.1780","article-title":"Naturally occurring IgM anti-leukocyte autoantibodies (IgM-ALA) inhibit t cell activation and chemotaxis","volume":"180","author":"Lobo","year":"2014","journal-title":"J. Immunol."},{"key":"10.1016\/j.molimm.2020.12.027_bib0180","doi-asserted-by":"crossref","first-page":"9579","DOI":"10.1073\/pnas.97.17.9579","article-title":"Multiple functional defects in peripheral autonomic organs in mice lacking muscarinic acetylcholine receptor gene for the M3 subtype","volume":"97","author":"Matsui","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.molimm.2020.12.027_bib0185","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaut.2014.01.001","article-title":"Sjogren\u2019s syndrome: a forty-year scientific journey","volume":"51","author":"Moutsopoulos","year":"2014","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.molimm.2020.12.027_bib0190","doi-asserted-by":"crossref","first-page":"e60726","DOI":"10.1371\/journal.pone.0060726","article-title":"Natural IgG autoantibodies are abundant and ubiquitous in human sera, and their number is influenced by age, gender, and disease","volume":"8","author":"Nagele","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.molimm.2020.12.027_bib0195","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1002\/1529-0131(200010)43:10<2297::AID-ANR18>3.0.CO;2-X","article-title":"Evidence for antimuscarinic acetylcholine receptor antibody-mediated secretory dysfunction in nod mice","volume":"43","author":"Nguyen","year":"2000","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.molimm.2020.12.027_bib0200","first-page":"e467","volume":"41","author":"Pers","year":"2012"},{"key":"10.1016\/j.molimm.2020.12.027_bib0205","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1111\/j.1476-5381.2009.00449.x","article-title":"Protease-activated receptors and prostaglandins in inflammatory lung disease","volume":"158","author":"Peters","year":"2009","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.molimm.2020.12.027_bib0210","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1146\/annurev.physiol.69.022405.154731","article-title":"Physiological roles of G protein\u2013coupled receptor kinases and arrestins","volume":"69","author":"Premont","year":"2007","journal-title":"Annu. Rev. Physiol."},{"key":"10.1016\/j.molimm.2020.12.027_bib0215","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1002\/eji.200738113","article-title":"Deficiency of Act1, a critical modulator of B cell function, leads to development of Sj\u00f6gren\u2019s syndrome","volume":"38","author":"Qian","year":"2008","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.molimm.2020.12.027_bib0220","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1172\/JCI1422","article-title":"The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions","volume":"101","author":"Qin","year":"1998","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.molimm.2020.12.027_bib0225","first-page":"1","article-title":"Difference in clinical presentation between women and men in incident primary Sj\u00f6gren\u2019s syndrome","volume":"8","author":"Ram\u00edrez Sep\u00falveda","year":"2017","journal-title":"Biol. Sex Differ."},{"key":"10.1016\/j.molimm.2020.12.027_bib0230","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1136\/ard.2010.135772","article-title":"Involvement of functional autoantibodies against vascular receptors in systemic sclerosis","volume":"70","author":"Riemekasten","year":"2011","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.molimm.2020.12.027_bib0235","doi-asserted-by":"crossref","first-page":"7538","DOI":"10.1073\/pnas.95.13.7538","article-title":"Transfer of human serum IgG to nonobese diabetic Igmu null mice reveals a role for autoantibodies in the loss of secretory function of exocrine tissues in Sj\u00f6gren\u2019s syndrome","volume":"95","author":"Robinson","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.molimm.2020.12.027_bib0240","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1136\/ard.2010.129049","article-title":"Peptide-based ELISAs are not sensitive and specific enough to detect muscarinic receptor type 3 autoantibodies in serum from patients with Sjogren\u2019s syndrome","volume":"70","author":"Roescher","year":"2011","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.molimm.2020.12.027_bib0245","first-page":"212","article-title":"Saliva composition and caries development in asthmatic patients treated with beta 2-adrenoceptor agonists: a 4-year follow-up study","volume":"99","author":"Ryberg","year":"1991","journal-title":"Scand. J. Dent. Res."},{"key":"10.1016\/j.molimm.2020.12.027_bib0250","first-page":"79","article-title":"plotROC\u202f: a tool for plotting ROC curves","author":"Sachs","year":"2017","journal-title":"J. Stat. Softw."},{"key":"10.1016\/j.molimm.2020.12.027_bib0255","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.coi.2004.09.012","article-title":"Chemoattractants and their receptors in homeostasis and inflammation","volume":"16","author":"Sallusto","year":"2004","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.molimm.2020.12.027_bib0260","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1136\/ard.2009.110619","article-title":"EULAR Sj\u00f6gren\u2019s syndrome disease activity index: development of a consensus systemic disease activity index for primary Sj\u00f6gren\u2019s syndrome","volume":"69","author":"Seror","year":"2010","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.molimm.2020.12.027_bib0265","doi-asserted-by":"crossref","first-page":"2581","DOI":"10.4049\/jimmunol.176.4.2581","article-title":"Epithelial CXCR3-B regulates chemokines bioavailability in normal, but not in Sj\u00f6gren\u2019s syndrome, salivary glands","volume":"176","author":"Sfriso","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.molimm.2020.12.027_bib0270","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S0140-6736(74)91815-7","article-title":"Thyroid-stimulating immunoglobulins in graves\u2019 disease","volume":"304","author":"Smith","year":"1974","journal-title":"Lancet"},{"key":"10.1016\/j.molimm.2020.12.027_bib0275","doi-asserted-by":"crossref","first-page":"141","DOI":"10.3109\/08916938809001927","article-title":"Ageing and autoantibodies","volume":"1","author":"Tomer","year":"1988","journal-title":"Autoimmunity"},{"key":"10.1016\/j.molimm.2020.12.027_bib0280","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1136\/ard.61.6.554","article-title":"Classification criteria for Sj\u00f6gren\u2019s syndrome: a revised version of the European criteria proposed by the American-European Consensus Group","volume":"61","author":"Vitali","year":"2002","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.molimm.2020.12.027_bib0285","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1186\/s13046-018-0858-4","article-title":"Protease-activated receptor-1 (PAR1) promotes epithelial-endothelial transition through Twist1 in hepatocellular carcinoma","volume":"37","author":"Xiao","year":"2018","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.molimm.2020.12.027_bib0290","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.2741\/4689","article-title":"Autoantibodies against muscarinic acetylcholine receptor M 3 in Sjogren\u2019s syndrome and corresponding mouse models","volume":"23","author":"Yu","year":"2018","journal-title":"Front Biosci (Landmark Ed)."},{"key":"10.1016\/j.molimm.2020.12.027_bib0295","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2017.01384","article-title":"B cells are indispensable for a novel mouse model of primary Sj\u00f6gren\u2019s syndrome","volume":"8","author":"Zheng","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.molimm.2020.12.027_bib0300","first-page":"1247","article-title":"Are autoantibodies against a 25-mer synthetic peptide of M3 muscarinic acetylcholine receptor a new diagnostic marker for Sj\u00f6gren\u2019s syndrome?","volume":"64","author":"Zigon","year":"2005","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.molimm.2020.12.027_bib0305","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.jim.2016.07.003","article-title":"Muscarinic type 3 receptor autoantibodies are associated with anti-SSA\/Ro autoantibodies in Sj\u00f6gren\u2019s syndrome","volume":"437","author":"Zuo","year":"2016","journal-title":"J. Immunol. Methods"}],"container-title":["Molecular Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161589020305940?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161589020305940?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T13:37:53Z","timestamp":1758980273000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161589020305940"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":61,"alternative-id":["S0161589020305940"],"URL":"https:\/\/doi.org\/10.1016\/j.molimm.2020.12.027","relation":{},"ISSN":["0161-5890"],"issn-type":[{"value":"0161-5890","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Autoantibodies against C5aR1, C3aR1, CXCR3, and CXCR4 are decreased in primary Sjogren\u2019s syndrome","name":"articletitle","label":"Article Title"},{"value":"Molecular Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molimm.2020.12.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}